Cited by 695Fatty Acid Research and HealthInflammatory mediators and NSAID effectsSphingolipid Metabolism and Signaling

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

Open access
Spite, Matthew, Norling, Lucy V., Summers, Lisa, Yang, Rong, Cooper, Dianne, Petasis, Nicos A., Flower, Roderick J., Perretti, Mauro +1 more·2009·Nature

Abstract

A growing body of evidence indicates that resolution of acute inflammation is an active process. Resolvins are a new family of lipid mediators enzymatically generated within resolution networks that possess unique and specific functions to orchestrate catabasis, the phase in which disease declines. Resolvin D2 (RvD2) was originally identified in resolving exudates, yet its individual contribution in resolution remained to be elucidated. Here, we establish RvD2's potent stereoselective actions in reducing excessive neutrophil trafficking to inflammatory loci. RvD2 decreased leukocyte-endothelial interactions in vivo by endothelial-dependent nitric oxide production, and by direct modulation of leukocyte adhesion receptor expression. In mice with microbial sepsis initiated by caecal ligation and puncture, RvD2 sharply decreased both local and systemic bacterial burden, excessive cytokine production and neutrophil recruitment, while increasing peritoneal mononuclear cells and macrophage phagocytosis. These multi-level pro-resolving actions of RvD2 translate to increased survival from sepsis induced by caecal ligation and puncture and surgery. Together, these results identify RvD2 as a potent endogenous regulator of excessive inflammatory responses that acts via multiple cellular targets to stimulate resolution and preserve immune vigilance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature08541

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SPMs suppress inflammation but, unlike anti-inflammatory drugs, promote both repair and continued pathogen clearance.

    “From a translational perspective, SPMs suppress inflammation but, unlike anti-inflammatory drugs, these pro-resolving mediators promote both repair and continued pathogen clearance33,213–215.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N.
Affiliations
  • Brigham and Women's Hospital (US)
  • Queen Mary University of London (GB)
  • University of Southern California (US)
Corresponding author
Serhan, Charles N.
Venue
Nature
Published
2009-10
Volume
461
Issue
7268
Pages
1287-1291
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1974226247
Cited by
695
References
33
Citations by year
2026: 21 · 2025: 19 · 2024: 35 · 2023: 34 · 2022: 42 · 2021: 49 · 2020: 61 · 2019: 40 · 2018: 40 · 2017: 44 · 2016: 54 · 2015: 45 · 2014: 39 · 2013: 50 · 2012: 48
FWCI
38.72
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
Funders
  • Wellcome Trust (086867/Z/08/Z, 085903/Z/08)
  • Versus Arthritis (18445, 18103)
  • National Institutes of Health (4r37gm038765-19)
  • National Heart, Lung, and Blood Institute (HL087526, F32HL087526)
  • National Institute of General Medical Sciences (GM 38765, R01GM038765, R37-GM038765)
  • National Institute of Dental and Craniofacial Research (P50DE016191)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Keywords
resolvin D2, inflammation resolution, neutrophil trafficking, leukocyte-endothelium interaction, nitric oxide, leukocyte adhesion molecules, cecal ligation and puncture, bacterial load, macrophage phagocytosis, anti-inflammatory agents, host defense
MeSH terms
Animals, Docosahexaenoic Acids, Escherichia coli, Humans, Inflammation, Leukocytes, Macrophages, Male, Mice, Inbred C57BL, Nitric Oxide, Peritoneal Cavity, Peritonitis, Phagocytosis, Reactive Oxygen Species, Sepsis, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review